Reuters : Health (77)

Swiss drugmaker Roche confident sales growth will overcome generic threat

ZURICH - Swiss drugmaker Roche, encouraged by better than expected first-quarter sales, said it was confident new drugs will help to deliver revenue and profit growth even as its older medicines take a hit from cheaper copies.

Synairgen loses half its value as AstraZeneca dumps drug

LONDON - British biotech firm Synairgen lost nearly half its value on Thursday as partner AstraZeneca pulled the plug on an experimental drug designed to help patients fight common cold viruses.

Drugmaker AbbVie's profit, revenue beat as Humira sales rise

- AbbVie Inc's quarterly profit and revenue beat analysts' estimates, helped by demand for its top-selling treatment, Humira.

Bristol-Myers beats Wall St estimates, helped by Cancer drug Opdivo

NEW YORK - Bristol-Myers Squibb Co on Thursday posted better-than-expected first-quarter earnings, helped by growth from cancer drugs Opdivo and Yervoy and blood thinner Eliquis.

Celgene quarterly sales misses on soft demand for psoriasis drug

- U.S. biotechnology company Celgene Corp reported lower-than-expected sales, hurt in part by soft demand for its psoriasis treatment even as sales of its flagship drug Revlimid beat estimates.

South Korea fines Novartis $49 million over kickbacks, suspends insurance payment

SEOUL - South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won for offering doctors kickbacks to recommend the company's drugs, and also suspended insurance coverage for some of its drugs.

Conservatives back latest U.S. healthcare bill, obstacles remain

WASHINGTON - The conservative House Freedom Caucus came out in support of a reworked U.S. healthcare overhaul bill even though it would not fully repeal Democratic former President Barack Obama's signature healthcare law, the group said in a statement on Wednesday.

Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

- Merck & Co's cholesterol-reducing drug Vytorin faces competition for the first time ever after two companies announced progress on their generic versions of a drug that generated more than $1 billion in sales last year.

Pregnancy complications await childhood cancer survivors

- Women who manage to conceive after surviving childhood cancer may encounter treatment-related pregnancy and labor complications if they got radiation for their malignancies, a recent study suggests.

White House to keep paying Obamacare subsidies for now: official

WASHINGTON - The Trump administration will continue to pay subsidies for low-income Americans receiving healthcare coverage under Obamacare, but no decisions have been made about future funding, a White House official said on Wednesday.

Cheap blood drug could prevent thousands of maternal deaths in developing world

LONDON - A cheap and widely available drug could save the lives of one in three of the 100,000 new mothers who bleed to death after childbirth every year, mostly in poorer countries, according to the first study of its use in postpartum haemorrhage.

UK plain cigarette pack law seen cutting number of smokers by 300,000

LONDON - The introduction of plain packaging for tobacco cigarettes sold in Britain from next month could cut the number of smokers in the country by another 300,000 within a year, researchers said on Thursday.

Drugs firms call for phased transition of regulation after Brexit

LONDON - Pharmaceutical companies called on Thursday for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.

Global foundation launches value-based healthcare pilots

- Key healthcare stakeholders, led by the World Economic Forum, plan pilot programs this year to show the value of a new model for healthcare that would track and pay for treatment based on how well it works rather than the volume of care.

Potentially harmful effects of energy drinks - it's not the caffeine

- Drinking 32 ounces of energy drink is associated with potentially harmful changes in blood pressure and heart function that are beyond those seen with caffeine alone, according to a new study.

Study finds how polluting nanoparticles get into blood and damage hearts

LONDON - Inhaled nanoparticles like those pumped out in vehicle exhausts can work their way through the lungs and into the bloodstream where they can raise the risk of heart attack and stroke, scientists said on Wednesday.

AstraZeneca third-line lung cancer trial delayed by few months

LONDON - A clinical study testing AstraZeneca's experimental immunotherapy drugs in lung cancer patients who have already received at least two previous treatments will take longer than initially expected to produce results.

Pregnant women need routine blood pressure checks

- Pregnant women should get their blood pressure checked at each prenatal visit to screen for preeclampsia, a potentially fatal complication that can damage the kidneys, liver, eyes and brain, new U.S. guidelines say.

Ok to wait for colonoscopy after positive fecal test results

- People who wait up to nine months to get a colonoscopy after fecal tests show potential tumors are no more likely to be diagnosed with cancer or advanced malignancies than those who get follow-up colonoscopies sooner, a U.S. study suggests.

U.S. House bill would exempt e-cigarettes from tobacco regulations

- A bill expected this week in the U.S. House of Representatives would weaken a Food and Drug Administration rule governing e-cigarettes and represent a major victory for the $4.4 billion U.S. vaping industry.

Most U.S. patients would disclose sexual orientation to docs

- While most doctors think patients prefer not to disclose their sexual orientation, a new survey found people are willing to provide the information when asked.

Gender viewpoints similar in trans preschoolers and other kids

- Transgender preschoolers are no less confident than their peers about their gender, a new study found.

Can playground design help reduce bullying?

- Playgrounds designed with risk-taking in mind may mean more pushing and shoving during recess, but they also might make kids less likely to feel bullied, a small experiment in New Zealand suggests.

Novartis to speed up bid for MS drug approval, changes target

ZURICH - Novartis said on Tuesday it would accelerate its bid to win approval for its experimental multiple sclerosis drug BAF312 and said it was now targeting patients at an earlier stage of the neurological disease.

Swedish authorities says bird flu found at hen farm

STOCKHOLM - An outbreak of H5N8 bird flu has been detected at a hen farm near the town of Nykoping in eastern Sweden, the country's board of agriculture said on Tuesday.

Taiwan eyes U.N. health meet, risks setback in China ties

TAIPEI - Taiwan faces a more complicated task this year in seeking to attend a U.N. health agency meeting than it has in the past, a senior official said on Tuesday, as the self-ruled island braces for another setback in ties with rival China.

Novartis sets sights on return to growth in 2018

ZURICH - Novartis reported better than expected first-quarter profits on Tuesday with Chief Executive Joe Jimenez saying he remained confident that the Swiss drugmaker would return to growth in 2018 as spending to promote new drugs pays off.

AstraZeneca moving costs rise as new HQ nears completion

LONDON - AstraZeneca's move to the English university city of Cambridge will cost more and take longer than initially expected, following increased expenditure on new technology and equipment.

Health insurer Centene's quarterly profit, revenue beat Street

- Health insurer Centene Corp reported better-than-expected quarterly revenue and profit, helped by its Health Net acquisition and growth in its Obamacare individual business.

Biogen revenue, profit beat Street on strong Spinraza launch

- Biogen Inc reported quarterly revenue and profit that beat analysts' estimates, boosted by strong sales of recently launched spinal muscular atrophy drug Spinraza.

Japan's Otsuka aims to apply for TB drug approval in India in 90 days

MUMBAI - Japanese drugmaker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis drug delamanid in India within three months, a senior company official said, as calls grow for expanded access to the life-saving medicine.

Government costs could rise $2.3 billion without Obamacare payments: study

WASHINGTON - The U.S. government's costs could increase by $2.3 billion in 2018 if Congress and President Donald Trump decide not to fund Obamacare-related payments to health insurers, according to a study released Tuesday by the Kaiser Family Foundation.

White House says vote on healthcare plan may not come for weeks

WASHINGTON - A congressional vote on a Republican healthcare plan may not come for weeks as leaders in the House of Representatives and the Senate continue negotiations over possible proposals, the White House said on Monday.

Mindfulness-based stress reduction only slightly improves low back pain

- - Mindfulness-based stress reduction programs appear to improve low back pain only slightly, and only temporarily, a review of previous research suggests.

Poorest preschoolers most vulnerable to fatal child abuse

- Children in America's poorest communities have three times the risk of dying from child abuse before age 5 as children in the wealthiest neighborhoods, a new study finds.

Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen

- Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices.

Canada recommends against testing everyone for hepatitis C

- Adults who don't have an increased risk of hepatitis C infection should not be tested for it, the Canadian Task Force on Preventive Health Care recommended today.

Diet and gut bacteria linked with blood clots

- Consuming too much choline, a nutrient sold in over-the-counter dietary supplements, can boost the risk for blood clots, researchers warn.

Childhood death of sibling might affect survivor's lifespan

- Death of a sibling in childhood is associated with a greater risk of early death in the surviving brother or sister, researchers say.

Lilly reports positive interim data on breast cancer combo drug

- Eli Lilly and Co said the combination of its experimental breast cancer drug and a commonly used treatment met the main goal of a late-stage study in an interim analysis, setting the stage for a regulatory submission later this year.

Iran reports H5N1 bird flu outbreak in northern part of country: OIE

PARIS - Iran has reported an outbreak of the highly contagious H5N1 bird flu virus in backyard ducks in the northern part of the country, the World Organisation for Animal Health said on Monday, citing a report from the Iranian agriculture ministry.

China to ramp up crack-down on 'gutter oil'

BEIJING - China will intensify a crack down on the use of recycled "gutter oil", strengthening controls on oil origins and monitoring processing, according to a document released by the State Council on Monday.

Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

LONDON - Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said on Monday.

Vaccination gaps lead to dangerous measles outbreaks in Europe: ECDC

LONDON - Gaps in vaccination coverage against measles have lead to several outbreaks of the highly-contagious disease in Europe in the past year, with both children and young adults affected, health officials said on Monday.

Becton Dickinson to acquire Bard for $24 billion

NEW YORK - U.S. medical equipment supplier Becton Dickinson and Co will acquire C R Bard Inc, in a $24 billion cash-and-stock deal, adding Bard's devices to its portfolio in the high-growth sectors of oncology and surgery, both companies said on Sunday.

EU drugmakers urge June decision on new location for watchdog

FRANKFURT - Europe's drugmakers pushed for a decision as early as June on the new location for the headquarters of the bloc's medicines watchdog, which will relocate from London after Britain's decision to leave the EU.

FDA approves Samsung Bioepis' copy of J&J's Remicade: company

SEOUL - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the United States.

Bristol-Myers NASH drug reduces liver fat in midstage study

- Bristol-Myers Squibb Co said its lead experimental drug for nonalcoholic steatohepatitis, or NASH, significantly reduced liver fat versus placebo, according to data from a mid-stage trial presented at a medical meeting on Saturday.

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug

- A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat rheumatoid arthritis.

Clash of science and politics "dangerous"-EU food safety chief

LONDON, April 21 - Politicians who attack the EU agency that ruled the weedkiller glyphosate probably does not cause cancer are in danger of undermining the effectiveness of a body that is key to keeping Europeans safe, its chief warned.